Navigation Links
Cardiolipin IgM II

ProductsCardiolipin IgM II
Company Inverness Medical Innovations
Item Cardiolipin IgM II
Features 
  • A choice of incubation protocols - manual or automated - all in one kit.
  • Most assays use interchangeable substrate, stop solution, and wash buffer. This uniformity of reagents allows for ease-of-automation with microtiter processing systems.
  • Breakaway, removable test wells in a microplate format. Color coded ready-to-use reagents are provided
  • SAVe Dilutent™ in most ELISA II IgG tests, to provide visual sample verification.
Description Our ELISA products for autoimmune testing feature single-well ANA screen and ENA screen ELISAs, as well as specific reflex tests including dsDNA, and 6 individual ENA kits: Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and Jo-1. In addition, our autoimmune ELISA family includes a full line of products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, Thyroid Microsomal, MPO, PR3, Rheumatoid Factor and the new anti-CCP ELISA, a highly specific assay for rheumatoid arthritis.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. ImmuLisa™ IgA-ACA anti-Cardiolipin Antibody (ACA) Kit
2. ImmuLisa™ IgG-ACA anti-Cardiolipin Antibody (ACA) Kit
3. ImmuLisa™ IgM-ACA anti-Cardiolipin Antibody (ACA) Kit
4. ImmunoWELL Cardiolipin Antibody (IgG) Test
5. ImmunoWELL Cardiolipin Antibody (IgM) Test
6. Anti-Cardiolipin Antibodies, IgG & IgM
7. Anti-Cardiolipin Antibody, IgG
8. Anti-Cardiolipin Antibody, IgM
9. Cardiolipin IgA II
10. Cardiolipin IgG II
11. Cardiolipin IgG, A, M
Our Reticulocyte Stain is a specialized hematology stain for identifying immature erythrocytes. These immature erythrocytes stain blue in a fine mesh network within the erythrocyte. Mature erythrocyt...
... Stain is a single solution ... buffer, and stain for rapid ... smears. It is packaged in ... of use and is suitable ...
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....
Medicine Products:
(Date:5/6/2016)... , ... May 06, 2016 , ... Canadian author Mark Black is a ... Life From the Heart" around the world … with the help of his publisher Strategic ... 24, Mark Black lay in a hospital bed waiting for a miracle: He needed a ...
(Date:5/6/2016)... ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... he has found in the Bible about helping to stop cancer. Yisrayl says there are ... his hope that the health and science industries will pay close attention and take action. ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... David Konur, CEO of Cardiovascular Institute of the South announced today that Dr. ... a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. , ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession ... the impact our aging population has on communities and resources. Aging Life Care plays ... and face age-related challenges. , Aging Life Care is a holistic, client-centered approach ...
(Date:5/5/2016)... ... May 05, 2016 , ... The U.S. Food and ... e-cigarette manufacturers to submit their products through an arduous federal approval process. The ... that entered the market since February 15, 2007. That would essentially ban 99 ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute Myeloid Leukemia Market and ... their offering.       (Logo: ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Myeloid Leukemia epidemiology, Acute ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
Breaking Medicine Technology: